Showing 5,599 results

Filters Content type: Editors' picks Country: North America
Government, leadership & policy

President Biden’s 2022 State of the Union Address

Editor's pick
HIV.gov
7 March 2022
Prisoners

US Study Reveals Delays, Copays and Stigma for HIV-Positive People in Jail

Editor's pick
POZ
2 March 2022
New & experimental HIV treatments

U.S. FDA declines to approve Gilead's HIV drug on glass vial concerns

Editor's pick
Reuters
1 March 2022
PrEP policies & guidelines

Many Americans still paying high costs months after insurers were ordered to cover HIV preventive care

Editor's pick
CNN
1 March 2022
Ethnic & cultural minorities

Georgia’s Black community disproportionately affected by HIV

Editor's pick
San Francisco Chronicle
28 February 2022
Health services & systems

ADAP Is Not Keeping Pace With Increasing HIV in Black and Latino Communities

Editor's pick
POZ
28 February 2022
People who inject drugs

SSA notes: The Lancet Commission and the North American opioid crisis

Editor's pick
Society for the Study of Addiction
28 February 2022
Epidemiology

Most Large HIV Molecular Clusters in US Primarily Involve MSM

Editor's pick
NATAP
24 February 2022
Dating, relationships & feelings

Centering Sexual Satisfaction in the PrEP Conversation

Editor's pick
POZ
24 February 2022
Activism & civil society

What Makes an Activist?

Editor's pick
POZ
15 February 2022
Transgender people

Trade-Off for Trans Women Between Hormones and Heart Risk

Editor's pick
POZ
15 February 2022
Vaccinations & immunisations

New Yorkers With HIV Are Less Likely to Be Vaccinated Against COVID-19

Editor's pick
POZ
14 February 2022
Injectable & long-acting PrEP

Members of Congress ask CDC to cut cost of new HIV prevention drug

Editor's pick
The Hill
14 February 2022
People who inject drugs

HIV incidence rising steeply among people who inject drugs in Tijuana

Editor's pick
EurekAlert
14 February 2022
Economic & social inequality

HIV diagnoses among Black adults highest in US communities with more social vulnerabilities

Editor's pick
Healio
7 February 2022
PrEP policies & guidelines

When you're charged a PrEP copay you shouldn't owe

Editor's pick
Axios
2 February 2022
Harm reduction

It’s Time for Maine to Free Us From One-to-One Syringe Distribution

Editor's pick
Filter
2 February 2022
Treatment outcomes & life expectancy

Improvements in survival for people with HIV continue to be achieved

Editor's pick
CATIE
2 February 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment

Editor's pick
ViiV press release
1 February 2022
HIV & criminal law

New Jersey Repeals Outdated HIV Crime Laws and Fights Stigma

Editor's pick
POZ
1 February 2022
Harm reduction

More Syringe Exchanges Can Open in New Jersey, Thanks to a New Law

Editor's pick
POZ
25 January 2022
Pregnancy and vertical transmission

Updated US Guidelines: TAF In, Cabenuva Out for Pregnant People

Editor's pick
POZ
25 January 2022
Vaginal rings & topical PrEP

HIV Prevention Vaginal Ring Withdrawn From FDA Consideration

Editor's pick
Medscape (requires free registration)
25 January 2022
Vaccinations & immunisations

People living with HIV need tailored COVID-19 vaccination information

Editor's pick
EurekAlert
24 January 2022